Silencing of osterix expression by siRNA inhibits aldosterone‑induced calcification of vascular smooth muscle cells in mice

Gong,Yan‑Chun; He,Yue; Wang,Hao; Niu,Wen‑Quan; Ji,Kai‑Da; Li,Hua

doi:10.3892/mmr.2016.5484

Silencing of osterix expression by siRNA inhibits aldosterone‑induced calcification of vascular smooth muscle cells in mice

Authors:
- Yan‑Chun Gong
- Yue He
- Hao Wang
- Wen‑Quan Niu
- Kai‑Da Ji
- Hua Li
View Affiliations

Affiliations: Department of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China, The Experimental Center of Basic Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, P.R. China, Shanghai Key Laboratory of Vascular Biology, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China
Published online on: July 8, 2016 https://doi.org/10.3892/mmr.2016.5484
Pages: 2111-2118

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The process of vascular calcification shares numerous similarities with that of skeletal mineralization and involves the deposition of hydroxyapatite crystals in arteries and cardiac valves. However, the underlying cellular mechanism remains to be fully elucidated. Microarray analysis in the present study demonstrated that greater than 2,000 genes were upregulated during the calcification of murine vascular smooth muscle cells (VSMCs), of which osterix (OSX) and integrin‑binding sialoprotein (IBSP) were the most significantly differentially expressed genes. Following the validation of increased OSX and IBSP expression by reverse transcription‑quantitative polymerase chain reaction in calcifying murine VSMCs induced by aldosterone. Subsequent to transfection with siRNA‑OSX, results indicated that OSX may inhibit calcification of VSMCs via IBSP. It was suggested that the increased OSX expression in calcifying VSMCs may reflect the well‑established prenatal role of OSX. A full understanding of the importance of OSX in this pathological process would improve understanding of the pathogenesis of vascular calcification.

View Figures

View References

1	Huang L, Teng XY, Cheng YY, Lee KM and Kumta SM: Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone. Bone. 34:393–401. 2004. View Article : Google Scholar : PubMed/NCBI
2	Chen MLY and Miao LY: OSX expression during the development of human teeth. Oral Med Res. 22:372–337. 2006.
3	Cao Y, Zhou Z, de Crombrugghe B, Nakashima K, Guan H, Duan X, Jia SF and Kleinerman ES: Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma. Cancer Res. 65:1124–1128. 2005. View Article : Google Scholar : PubMed/NCBI
4	Kim YJ, Kim HN, Park EK, Lee BH, Ryoo HM, Kim SY, Kim IS, Stein JL, Lian JB, Stein GS, et al: The bone-related Zn finger transcription factor Osterix promotes proliferation of mesenchymal cells. Gene. 366:145–151. 2006. View Article : Google Scholar
5	Zhou YS, Liu YS and Tan JG: Is 1, 25-dihydroxyvitamin D3 an ideal substitute for dexamethasone for inducing osteogenic differentiation of human adipose tissue-derived stromal cells in vitro? Chin Med J (Engl). 119:1278–1286. 2006.
6	Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR and de Crombrugghe B: The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 108:17–29. 2002. View Article : Google Scholar : PubMed/NCBI
7	Demer LL and Tintut Y: Vascular calcification: Pathobiology of a multifaceted disease. Circulation. 117:2938–2948. 2008. View Article : Google Scholar : PubMed/NCBI
8	Shioi A: Molecular mechanisms of vascular calcification. Clin Calcium. 20:1611–1619. 2010.In Japanese. PubMed/NCBI
9	Wu SY, Yu YR, Cai Y, Jia LX, Wang X, Xiao CS, Tang CS and Qi YF: Endogenous aldosterone is involved in vascular calcification in rat. Exp Biol Med (Maywood). 237:31–37. 2012. View Article : Google Scholar
10	Radtke CL, Nino-Fong R, Rodriguez-Lecompte JC, Esparza Gonzalez BP, Stryhn H and McDuffee LA: Osteogenic potential of sorted equine mesenchymal stem cell subpopulations. Can J Vet Res. 79:101–108. 2015.PubMed/NCBI
11	Valenzuela CD, Allori AC, Reformat DD, Sailon AM, Allen RJ Jr, Davidson EH, Alikhani M, Bromage TG, Ricci JL and Warren SM: Characterization of adipose-derived mesenchymal stem cell combinations for vascularized bone engineering. Tissue Eng Part A. 19:1373–1385. 2013. View Article : Google Scholar : PubMed/NCBI
12	Staines KA, Zhu D, Farquharson C and MacRae VE: Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling. J Bone Miner Metab. 32:240–251. 2014. View Article : Google Scholar
13	Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B and Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31:e152003. View Article : Google Scholar : PubMed/NCBI
14	Kauffmann A, Gentleman R and Huber W: ArrayQuality-Metrics-a bioconductor package for quality assessment of microarray data. Bioinformatics. 25:415–416. 2009. View Article : Google Scholar
15	Macrae VE, Horvat S, Pells SC, Dale H, Collinson RS, Pitsillides AA, Ahmed SF and Farquharson C: Increased bone mass, altered trabecular architecture and modified growth plate organization in the growing skeleton of SOCS2 deficient mice. J Cell Physiol. 218:276–284. 2009. View Article : Google Scholar
16	Mohler ER III, Wang H, Medenilla E and Scott C: Effect of statin treatment on aortic valve and coronary artery calcification. J Heart Valve Dis. 16:378–386. 2007.PubMed/NCBI
17	Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, Orszulak T, Fullerton DA, Tajik AJ, Bonow RO and Spelsberg T: Human aortic valve calcification is associated with an osteoblast phenotype. Circulation. 107:2181–2184. 2003. View Article : Google Scholar : PubMed/NCBI
18	Alexopoulos A, Bravou V, Peroukides S, Kaklamanis L, Varakis J, Alexopoulos D and Papadaki H: Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves. Int J Cardiol. 139:142–149. 2010. View Article : Google Scholar
19	Taylor J, Butcher M, Zeadin M, Politano A and Shaughnessy SG: Oxidized low-density lipoprotein promotes osteoblast differentiation in primary cultures of vascular smooth muscle cells by up-regulating Osterix expression in an Msx2-dependent manner. J Cell Biochem. 112:581–588. 2011. View Article : Google Scholar : PubMed/NCBI
20	Samee N, Geoffroy V, Marty C, Schiltz C, Vieux-Rochas M, Levi G and de Vernejoul MC: Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling. Am J Pathol. 173:773–780. 2008. View Article : Google Scholar : PubMed/NCBI
21	Igarashi M, Kamiya N, Hasegawa M, Kasuya T, Takahashi T and Takagi M: Inductive effects of dexamethasone on the gene expression of Cbfa1, Osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts. J Mol Histol. 35:3–10. 2004. View Article : Google Scholar : PubMed/NCBI